We are live on ! Find out more
IGC icon

IGC Pharma
IGC

20 hedge funds and large institutions have $872K invested in IGC Pharma in 2019 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 2

707% more capital invested

Capital invested by funds: $108K → $872K (+$764K)

400% more funds holding

Funds holding: 4 → 20 (+16)

87% more call options, than puts

Call options by funds: $88K | Put options by funds: $47K

1.06% more ownership

Funds ownership: 0% → 1.06% (+1.1%)

Holders
20
Holders Change
+16
Holders Change %
+400%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
2
Reduced
–
Closed
2
Calls
$88K
Puts
$47K
Net Calls
+$41K
Net Calls Change
+$41K

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$148K
2
Creative Planning
Creative Planning
Kansas
+$146K
3
Goldman Sachs
Goldman Sachs
New York
+$85K
4
SB
Suntrust Banks
Georgia
+$83.3K
5
Morgan Stanley
Morgan Stanley
New York
+$68.5K

Top Sellers

Rank Fund Capital Flow
1
CFA
Carroll Financial Associates
North Carolina
-$82K
Name Holding Trade Value Shares
Change 		Change in
Stake
DP
1
Dearborn Partners
Illinois
$214K +$21.8K +9,585 +10%
Bank of Montreal
2
Bank of Montreal
Ontario, Canada
$135K +$148K +65,000 New
Creative Planning
3
Creative Planning
Kansas
$133K +$146K +64,039 New
Goldman Sachs
4
Goldman Sachs
New York
$78K +$85K +37,380 New
SB
5
Suntrust Banks
Georgia
$76K +$83.3K +36,667 New
Morgan Stanley
6
Morgan Stanley
New York
$63K +$68.5K +30,150 New
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$43K +$47.2K +20,750 New
Cambridge Investment Research Advisors
8
Cambridge Investment Research Advisors
Iowa
$34K +$37.6K +16,540 New
TSS
9
Two Sigma Securities
New York
$30K +$33K +14,535 New
Jane Street
10
Jane Street
New York
$23K +$24.9K +10,971 New
UBS Group
11
UBS Group
Switzerland
$12K +$13K +5,727 New
Simplex Trading
12
Simplex Trading
Illinois
$10K +$10.7K +4,728 +2,364%
LTFS
13
Ladenburg Thalmann Financial Services
Florida
$9K +$9.77K +4,300 New
GWM
14
Geneos Wealth Management
Colorado
$6K +$7.27K +3,200 New
FANJ
15
Financial Architects (New Jersey)
New Jersey
$3K +$2.84K +1,250 New
AG
16
Advisor Group
Arizona
$3K +$3.03K +1,332 New
CFA
17
Carroll Financial Associates
North Carolina
– -$82K -216,000 Closed
SWM
18
SeaCrest Wealth Management
New York
– +$5 +2 New
Deutsche Bank
19
Deutsche Bank
Germany
– +$455 +200 New
Wells Fargo
20
Wells Fargo
California
– +$455 +200 New
CG
21
Cutler Group
California
– +$682 +300 New

IGC Hedge Fund Activity: Q1 2019 in Review

20 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q1 2019, worth a combined $872K — up 707% from $108K a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new IGC positions and 2 closed out — a net gain of 16 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $148K. The largest seller was Carroll Financial Associates, exiting entirely with an estimated $82K sold.

  • 20 institutional investors held IGC Pharma (IGC) as of Q1 2019, up from 4 in Q4 2018.
  • Funds reported $872K of IGC Pharma stock for Q1 2019, up 707% quarter-over-quarter.
  • 18 funds opened new IGC Pharma positions in Q1 2019 and 2 closed out, a net change of +16 holders.
  • The largest IGC Pharma buyer in Q1 2019 was Bank of Montreal, an estimated $148K added.
  • The largest IGC Pharma seller in Q1 2019 was Carroll Financial Associates, an estimated $82K sold.

Based on aggregated 13F filings for Q1 2019.